Clinical Trial Update: A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension [Phase 2]

View source ↗

Summary

This document reports a Phase 2 dose-selection trial evaluating the combination of candesartan cilexetil and amlodipine besylate for essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Amlodipine besylate (amlodipine besylate)
• candesartan cilexetil (candesartan cilexetil)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Essential Hypertension | Phase 2 | Status: UNKNOWN